They set up a policy where compounders could work around FDA approval guidelines in cases of shortages. But right now, there is no shortage of GLP-1 medications, and because companies like Eli Lilly and Novo Nordisk have patents, patients are likely years away from FDA-approved generics
We were both dealing with stubborn weight that diet and gym sessions just were not touching anymore
One in 8 American adults reports using a glucagon-like peptide 1 receptor agonist (GLP-1RA) medication, and prescriptions continue to increase due to these drugs effectiveness in reducing cardiovascular mortality and treating diabetes and obesity
CrossRef Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Multisystemic Narrative Review of Cardiovascular and Oncological Implications Menatalla M
Benefits May Include: Better regulate appetite Increased feelings of fullness Lose fat and retain muscle
While we await dedicated cardiovascular outcomes trials for Retatrutide, I believe the constellation of metabolic improvements points strongly toward cardioprotection